Replies to post #161904 on Biotech Values

[pcrutch]

I have heard that their data is really good

[Checkpoint]

Dew, you confuse me with the word boldly. Everyone should know the anti PD1 antibodies are more robust in response rate and survival then Anti Ctla4. If Merck hopes to have an answer to Bristol lead they better boldly figure out how they are going to do combination studies.